• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation in Atrial Fibrillation Patients With Frailty.

作者信息

Lee Justin Z

机构信息

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

JACC Case Rep. 2024 Nov 20;29(22 Suppl):102687. doi: 10.1016/j.jaccas.2024.102687.

DOI:10.1016/j.jaccas.2024.102687
PMID:39790117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707417/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2659/11707417/66d36a205904/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2659/11707417/66d36a205904/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2659/11707417/66d36a205904/fx1.jpg

相似文献

1
Anticoagulation in Atrial Fibrillation Patients With Frailty.老年心房颤动患者的抗凝治疗
JACC Case Rep. 2024 Nov 20;29(22 Suppl):102687. doi: 10.1016/j.jaccas.2024.102687.
2
Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation.抗凝治疗与衰弱对老年房颤患者的影响
Clin Interv Aging. 2024 Feb 14;19:247-254. doi: 10.2147/CIA.S453527. eCollection 2024.
3
Differential effect of anticoagulation according to cognitive function and frailty in older patients with atrial fibrillation.抗凝治疗在老年房颤患者中的认知功能和虚弱程度的差异影响。
J Am Geriatr Soc. 2023 Feb;71(2):394-403. doi: 10.1111/jgs.18079. Epub 2022 Oct 23.
4
What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis.衰弱对老年房颤患者抗凝治疗处方有何影响？一项系统评价和荟萃分析。
J Atr Fibrillation. 2018 Apr 30;10(6):1870. doi: 10.4022/jafib.1870. eCollection 2018 Apr.
5
Impact of Frailty on Bleeding Events Related to Anticoagulation Therapy in Patients With Atrial Fibrillation.衰弱对房颤患者抗凝治疗相关出血事件的影响。
Circ J. 2021 Feb 25;85(3):235-242. doi: 10.1253/circj.CJ-20-0373. Epub 2021 Jan 27.
6
Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study.口服抗凝药在伴发房颤的虚弱患者中的净临床获益：全国队列研究。
Stroke. 2024 Feb;55(2):413-422. doi: 10.1161/STROKEAHA.123.044407. Epub 2024 Jan 22.
7
Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.老年人房颤患者的生理、认知和心理社会状况与抗凝满意度的关系：SAGE-AF 研究。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2508-2515. doi: 10.1111/jce.14176. Epub 2019 Sep 25.
8
Impact of geriatric syndromes on anticoagulation prescription in older adults with atrial fibrillation.老年综合征对老年心房颤动患者抗凝处方的影响。
Curr Med Res Opin. 2022 Mar;38(3):339-343. doi: 10.1080/03007995.2021.2000717. Epub 2021 Nov 12.
9
Very Elderly Patients With Atrial Fibrillation Treated With Edoxaban: Impact of Frailty on Outcomes.使用依度沙班治疗的高龄房颤患者：衰弱对治疗结果的影响。
JACC Adv. 2023 Aug 24;2(7):100569. doi: 10.1016/j.jacadv.2023.100569. eCollection 2023 Sep.
10
The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.出血风险和虚弱状态对老年房颤患者抗凝模式的影响：FRAIL-AF研究
Can J Cardiol. 2016 Feb;32(2):169-76. doi: 10.1016/j.cjca.2015.05.012. Epub 2015 May 27.

本文引用的文献

1
Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.直接口服抗凝药物的药代动力学和药效学。
Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):911-923. doi: 10.1080/17425255.2023.2287472. Epub 2024 Jan 12.
2
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial. frail 老年房颤患者由维生素 K 拮抗剂转换为非维生素 K 拮抗剂口服抗凝剂的安全性：FRAIL-AF 随机对照试验结果。
Circulation. 2024 Jan 23;149(4):279-289. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub 2023 Aug 27.
3
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study.
阿哌沙班、达比加群、依度沙班和利伐沙班在房颤患者中的疗效和安全性比较：一项基于多国人群的队列研究。
Ann Intern Med. 2022 Nov;175(11):1515-1524. doi: 10.7326/M22-0511. Epub 2022 Nov 1.
4
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.老年非瓣膜性心房颤动患者的口服抗凝剂比较。
J Am Geriatr Soc. 2019 Aug;67(8):1662-1671. doi: 10.1111/jgs.15956. Epub 2019 May 21.
5
Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age.直接口服抗凝剂与华法林在>75 岁患者中的比较的荟萃分析。
Am J Cardiol. 2019 Jun 15;123(12):2051-2057. doi: 10.1016/j.amjcard.2019.02.060. Epub 2019 Mar 18.